June 05, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Children with type 1 diabetes had similar long-term glycemic outcomes with two different automated insulin delivery systems, researchers reported in a paper published in Diabetes Technology & Therapeutics. In a single-center study conducted at UPMC Children’s Hospital of Pittsburgh, researchers compared data between children with type 1 diabetes using the Omnipod 5 (Insulet) and those using
June 05, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Omnipod Pod Recall; Afrezza OK'd for Kids 6 and Up; CVS to Cover Zepbound Again

Telehealth booms as demand for GLP-1s surges and questions mount about safety, oversight

teplizumab per ritardare LADA (05/06/2026) | Forum Diabete | Il Medico Risponde - Corriere.it

Children and adults with type 1 diabetes who used a fast-acting mealtime insulin along with automated insulin delivery had…

Youths who start using an automated insulin delivery system within 6 months of type 1 diabetes diagnosis are 82% more likely to…

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong…

News and commentary from the endocrinology world

A digital weight management program reduced “food noise” for adults with obesity, with greater benefits observed among adults…

The FDA has approved technosphere insulin, an inhaled form of human insulin, for children and adolescents aged 6 years and older…